Integra LifeSciences Reports First Quarter 2024 Financial Results PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2024. First Quarter 2024 Highlights First quarter revenues of $368.9 million declined 3.1% on a reported basis and declined 2.5% on an organic basis compared to the prior year. Revenue increased 1.6% on an organic basis excluding BostonFirst quarter GAAP earnings per diluted share of $(0.04), compared to $0.29 in the prior year; adjusted ear...
A director at TD Synnex Corp sold 10,000 shares at 115.792USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Moody's Ratings ("Moody's") today affirmed CoStar Group, Inc.'s ("CoStar") Baa3 senior unsecured rating. The outlook remains stable. Governance, CoStar's prudent financial policy in particular, is a key driver of today's action. Moody's believes that the company's financial metrics will remain con...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.